These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22726113)

  • 1. Gluten-dependent intestinal autoimmune response.
    Korponay-Szabó IR; Simon-Vecsei Z; De Leo L; Not T
    Curr Pharm Des; 2012; 18(35):5753-8. PubMed ID: 22726113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K; Mäki M; Kaukinen K
    Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for anti-transglutaminase 2 autoantibodies in the pathogenesis of coeliac disease?
    Lindfors K; Kaukinen K; Mäki M
    Amino Acids; 2009 Apr; 36(4):685-91. PubMed ID: 18594945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
    Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
    BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathomechanisms in celiac disease.
    Dieterich W; Esslinger B; Schuppan D
    Int Arch Allergy Immunol; 2003 Oct; 132(2):98-108. PubMed ID: 14600421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coeliac disease--a meeting point for genetics, immunology, and protein chemistry.
    Mowat AM
    Lancet; 2003 Apr; 361(9365):1290-2. PubMed ID: 12699968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celiac disease: risk assessment, diagnosis, and monitoring.
    Setty M; Hormaza L; Guandalini S
    Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue transglutaminase--the key player in celiac disease: a review.
    Reif S; Lerner A
    Autoimmun Rev; 2004 Jan; 3(1):40-5. PubMed ID: 14871648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gluten: a two-edged sword. Immunopathogenesis of celiac disease.
    Koning F; Gilissen L; Wijmenga C
    Springer Semin Immunopathol; 2005 Sep; 27(2):217-32. PubMed ID: 16091925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase, gluten and celiac disease: food for thought. Transglutaminase is identified as the autoantigen of celiac disease.
    Marsh MN
    Nat Med; 1997 Jul; 3(7):725-6. PubMed ID: 9212095
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue transglutaminase in celiac disease: role of autoantibodies.
    Caputo I; Barone MV; Martucciello S; Lepretti M; Esposito C
    Amino Acids; 2009 Apr; 36(4):693-9. PubMed ID: 18600381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease.
    Martucciello S; Sposito S; Esposito C; Paolella G; Caputo I
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
    Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I
    Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of coeliac disease.
    Dewar D; Pereira SP; Ciclitira PJ
    Int J Biochem Cell Biol; 2004 Jan; 36(1):17-24. PubMed ID: 14592529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.
    Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I
    Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet.
    Not T; Ziberna F; Vatta S; Quaglia S; Martelossi S; Villanacci V; Marzari R; Florian F; Vecchiet M; Sulic AM; Ferrara F; Bradbury A; Sblattero D; Ventura A
    Gut; 2011 Nov; 60(11):1487-93. PubMed ID: 21471568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celiac disease: from pathogenesis to novel therapies.
    Schuppan D; Junker Y; Barisani D
    Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenic peptides can be detected in whole gluten by transamidating highly susceptible glutamine residues: implication in the search for gluten-free cereals.
    Mamone G; Camarca A; Fierro O; Sidney J; Mazzarella G; Addeo F; Auricchio S; Troncone R; Sette A; Gianfrani C
    J Agric Food Chem; 2013 Jan; 61(3):747-54. PubMed ID: 23244345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The production of the oral mucosa of antiendomysial and anti-tissue-transglutaminase antibodies in patients with celiac disease: a review.
    Compilato D; Campisi G; Pastore L; Carroccio A
    ScientificWorldJournal; 2010 Dec; 10():2385-94. PubMed ID: 21170489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies and CD: past and future of celiac antibody testing.
    Korponay-Szabó IR
    J Pediatr Gastroenterol Nutr; 2014 Jul; 59 Suppl 1():S11-3. PubMed ID: 24979192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.